Hanson McClain Advisors »

Spero Therapeutics shares owned by Hanson McClain Advisors

Quarter-by-quarter ownership of Spero Therapeutics (SPRO) shares owned by Hanson McClain Advisors from 13F filings

Historical chart of Hanson McClain Advisors investment in Spero Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Spero Therapeutics held by Hanson McClain Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Spero Therapeutics by Hanson McClain Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.0k 600 1.72
2023-12-31 $882 600 1.47
2023-09-30 $726 600 1.21
2023-06-30 $870 600 1.45
2023-03-31 $870 600 1.45
2022-12-31 $1.0k 600 1.73
2022-09-30 $1.0k 600 1.67
2022-06-30 $0 102 0.00